BRIEF-Psyence Biomed Announces Strategic Ibogaine Investment
Reuters2026/09/23 11:04Psyence Biomedical Ltd PBM.O:
PSYENCE BIOMED ANNOUNCES STRATEGIC IBOGAINE INVESTMENT
PSYENCE BIOMEDICAL -AGREES TO INVEST UP TO $5 MILLION IN PSYLABS, $2.40 MILLION COMMITTED
PSYENCE BIOMEDICAL - CO AND PSYLABS AGREE TO $9 MILLION VALUE-MATCHED SHARE EXCHANGE
PSYENCE BIOMEDICAL - POST-DEAL, PSYLABS TO HOLD 49.89% OF PSYENCE BIOMED, PSYENCE BIOMED 41.13% OF PSYLABS
Source text: ID:nGNX8m9Ck4
Further company coverage: PBM.O
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Two industry professionals have passed away in the past two weeks; please take care of your health.
Brutus Mining shares begin trading on Frankfurt Stock Exchange under symbol ZI3
Qualcomm agrees to acquire PickNik Robotics
Market Chatter: Brookfield in Talks to Buy Actimize for $2 Billion
Crypto prices
More
